{
  "ticker": "AURA",
  "company_name": "Aura Biosciences, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT06643884",
      "title": "Suprachoroidal Administration in Subjects With Metastases to the Choroid",
      "status": "RECRUITING",
      "phase": "PHASE2",
      "condition": "Eye Cancer, Primary Cancer",
      "start_date": "2024-12-16",
      "completion_date": "2027-10-31",
      "enrollment": 0,
      "sponsor": "Aura Biosciences"
    },
    {
      "nct_id": "NCT03941379",
      "title": "A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma",
      "status": "RECRUITING",
      "phase": "",
      "condition": "Choroidal Melanoma, Indeterminate Lesions of Eye",
      "start_date": "2019-03-27",
      "completion_date": "2029-12",
      "enrollment": 0,
      "sponsor": "Aura Biosciences"
    },
    {
      "nct_id": "NCT05483868",
      "title": "A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer",
      "status": "RECRUITING",
      "phase": "PHASE1",
      "condition": "Non-muscle-invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer (&Amp;#34;NMIBC&Amp;#34;) Unresponsive/Intolerant to BCG, NMIBC, Non-Muscle Invasive Bladder Carcinoma, Non-Muscle Invasive Bladder Neoplasms, Non-Muscle Invasive Bladder Urothelial Carcinoma, Urothelial Carcinoma Bladder",
      "start_date": "2022-09-26",
      "completion_date": "2027-03",
      "enrollment": 0,
      "sponsor": "Aura Biosciences"
    },
    {
      "nct_id": "NCT06007690",
      "title": "A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma",
      "status": "RECRUITING",
      "phase": "PHASE3",
      "condition": "Choroidal Melanoma, Indeterminate Lesions, Uveal Melanoma, Ocular Melanoma",
      "start_date": "2023-12-06",
      "completion_date": "2028-08-15",
      "enrollment": 0,
      "sponsor": "Aura Biosciences"
    },
    {
      "nct_id": "NCT05266430",
      "title": "Prospective Group-Matched Study With Belzupacap Sarotalocan (Bel-sar; AU-011) or Plaque Radiotherapy for Primary Indeterminate Lesions or Choroidal Melanoma (IL/ CM)",
      "status": "TERMINATED",
      "phase": "",
      "condition": "Choroidal Melanoma, Indeterminate Lesions",
      "start_date": "2022-04-14",
      "completion_date": "2023-04-20",
      "enrollment": 0,
      "sponsor": "Aura Biosciences"
    },
    {
      "nct_id": "NCT07338968",
      "title": "A Long-Term Follow-Up Study of Subjects Completing the AU-011-301(CoMpass) for Early Choroidal Melanoma",
      "status": "NOT_YET_RECRUITING",
      "phase": "",
      "condition": "Choroidal Melanoma, Indeterminate Lesions",
      "start_date": "2026-02-01",
      "completion_date": "2033-08-15",
      "enrollment": 0,
      "sponsor": "Aura Biosciences"
    },
    {
      "nct_id": "NCT04417530",
      "title": "Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Uveal Melanoma, Ocular Melanoma, Choroidal Melanoma",
      "start_date": "2020-08-05",
      "completion_date": "2024-04-22",
      "enrollment": 0,
      "sponsor": "Aura Biosciences"
    },
    {
      "nct_id": "NCT03052127",
      "title": "Study in Subjects With Small Primary Choroidal Melanoma",
      "status": "COMPLETED",
      "phase": "PHASE1, PHASE2",
      "condition": "Uveal Melanoma, Ocular Melanoma, Choroidal Melanoma",
      "start_date": "2017-02-27",
      "completion_date": "2021-01-26",
      "enrollment": 0,
      "sponsor": "Aura Biosciences"
    }
  ],
  "summary": {
    "total_trials": 8,
    "by_phase": {
      "PHASE2": 2,
      "": 3,
      "PHASE1": 1,
      "PHASE3": 1,
      "PHASE1, PHASE2": 1
    },
    "by_status": {
      "RECRUITING": 4,
      "TERMINATED": 1,
      "NOT_YET_RECRUITING": 1,
      "COMPLETED": 2
    },
    "active_trials": 4,
    "completed_trials": 2,
    "conditions": [
      "Choroidal Melanoma, Indeterminate Lesions",
      "Choroidal Melanoma, Indeterminate Lesions of Eye",
      "Choroidal Melanoma, Indeterminate Lesions, Uveal Melanoma, Ocular Melanoma",
      "Eye Cancer, Primary Cancer",
      "Non-muscle-invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer (&Amp;#34;NMIBC&Amp;#34;) Unresponsive/Intolerant to BCG, NMIBC, Non-Muscle Invasive Bladder Carcinoma, Non-Muscle Invasive Bladder Neoplasms, Non-Muscle Invasive Bladder Urothelial Carcinoma, Urothelial Carcinoma Bladder",
      "Uveal Melanoma, Ocular Melanoma, Choroidal Melanoma"
    ],
    "lead_stage": "phase_3"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:16:45.561314",
    "search_query": "Aura Biosciences, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Aura+Biosciences,+Inc."
  }
}